NYSE:IBO
Impact Biomedical Inc.
Impact Biomedical Inc.'s revenue was $32,000 in fiscal 2025.Summary generated from Impact Biomedical Inc.'s SEC filings. Latest annual report filed Mar 11, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$32,000
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross margin−1225.0%
Operating margin−13381.3%
Net margin−36993.8%
ROICn/a
Return on equity−140.4%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count changen/a
Financials
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 0 | n/a | n/a | 0 |
| Operating income | −3 | −4 | −29 | −4 |
| Net income | −7 | −4 | −25 | −12 |
| Free cash flow | n/a | n/a | n/a | n/a |
Recent filings
- 8-KAmendment to articles or bylaws
Oct 9, 2026 - 4Insider transaction report
Sep 24, 2026 - 8-KRegulation FD disclosure
Sep 17, 2026 - 8-KRegulation FD disclosure
Sep 15, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 12, 2026 - 4Insider transaction report
Mar 30, 2026 - 10-KAnnual report for the fiscal year ended Dec 31, 2025
Mar 11, 2026